ScholarWorks@Korea University: Yoon, Won Sup

Detailed Information

Yoon, Won Sup (윤원섭)

College of Medicine (Department of Medical Science)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Radiotherapy:20||Breast cancer:10||Hepatocellular carcinoma:9||Stereotactic body radiotherapy:8||radiotherapy:8||Radiation therapy:7||hepatocellular carcinoma:7||Brain metastasis:4||Adjuvant radiotherapy:3||sorafenib:3||Overall survival:3||radiation therapy:3||Metaanalysis:3||Adjuvant chemoradiotherapy:3||Complications:3||rectal cancer:3||metaanalysis:3||Nasopharyngeal carcinoma:2||Wholebrain radiotherapy:2||external beam radiotherapy:2||Recurrence:2||Liver neoplasm:2||Portal vein thrombosis:2||Risk factors:2||Concurrent chemoradiation therapy:2||survival:2||Adjuvant:2||방사선치료:2||Breast neoplasm:2||Cancer:2||Radiofrequency ablation:2||ultracentral tumor:2||IntensityModulated Radiation Therapy:2||Utilization:2||Tomotherapy:2||portal vein thrombosis:2||Quality of life:2||head and neck cancer:2||Imageguided radiotherapy:2||Preoperative chemoradiotherapy:2||BCLC C:2||breast cancer:2||chemoradiotherapy:2||liver neoplasm:2||Prognosis:2||Biological index:2||Uterine cervical cancer:2||Rectal neoplasms:2||Endometrial cancer:2||Spectrophotometer:2||toxicity:2||central tumor:2||Lung cancer:2||intensitymodulated radiotherapy:2||feasibility:2||Organs at risk:2||stereotactic body radiation therapy:1||Dietary habits:1||recurrence:1||Right decision:1||Radiation pneumonitis:1||Dose fractionation:1||Diagnosis:1||Management:1||Adjuvant treatment:1||Lymphatic metastasis:1||Adjuvant radiation therapy:1||Diseasefree survival:1||Clinical target volume:1||Recurrence patterns:1||Quality factor:1||Endometrial carcinoma:1||portal vein tumour thrombosis:1||Uterine Carcinosarcoma:1||Extendedfield RT:1||Quality assurance:1||3D dose evaluation program:1||Image registration:1||Nomogram:1||Cervical cancer:1||Respiration:1||Polymer gel:1||Radiation protection:1||Onboard imager:1||Prognostic factors:1||Postoperative chemoradiotherapy:1||circumferential extent:1||부작용:1||Braindirected treatment:1||radiochemotherapy:1||Metachronous Neoplasm:1||External beam radiation therapy:1||Hypofraction:1||Clinical guideline:1||Toxicity prediction:1||Guidelines:1||preoperative radiotherapy:1||Colorectal neoplasms:1||lung cancer:1||Selective internal radiotherapy:1||Toxicity:1||Combined modality therapy:1||Portal vein:1||radiotherapy dosage:1||PRESAGE (TM) gel dosimeter:1||Prostate cancer:1||Gross target volume:1||Postoperative radiotherapy:1||intensitymodulated radiation therapy:1||Dose linearity:1||Epithelium:1||interfractional variation:1||lymph nodes:1||Setup uncertainty:1||preoperative concurrent chemoradiotherapy:1||Surgery:1||Breast neoplasms:1||Stereotactic Radiotherapy:1||Salvage treatment:1||Survivorship:1||ultracentral (UC) tumor:1||stereotactic body radiotherapy (SBRT):1||Initiative:1||Prognostic model:1||Nonsmallcell lung carcinoma:1||Uterine cervical neoplasms:1||Tubular carcinoma:1||Breast cancer recurrence:1||Paraaortic recurrence:1||Endometrial neoplasms:1||Stage:1||Dosimetrical index:1||Nonsmall cell lung cancer:1||tumor volume:1||Optimization:1||Circumferential resection margin:1||Magnetic resonance imaging:1||Immobilization:1||Triphala:1||couch:1||tracking:1||고악성도 신경아교종:1||Prognostic factor:1||Uterine Cervical Neoplasm:1||pulmonary metastasis:1||concurrent:1||combined:1||transarterial chemoembolization:1||Physical activity:1||Head and neck cancer:1||stomach cancer:1||Cost:1||Whole brain radiotherapy:1||Carcinoma:1||hepatocellular:1||dietary habit:1||Cholangiocarcinoma:1||Stereotactic ablative body radiotherapy:1||Normal tissue complication probability:1||Treatment planning decision support system:1||guidelines:1||radiation treatment planning decision support program (PDSS):1||Chemoembolization:1||Optical CT scanner:1||Intensitymodulated radiation therapy:1||target volume:1||Lamina propria:1||Pelvic neoplasms:1||imageguided radiation therapy (IGRT):1||delay time:1||High grade glioma:1||nonsmall cell lung carcinoma:1||Lymphatic Metastasis:1||external beam radiation therapy:1||Mammaplasty:1||stereotactic ablative body radiotherapy:1||Policy:1||Stereotactic radiotherapy:1||reconstruction:1||cancer survivor:1||Hepatic arterial infusion chemotherapy:1||stereotactic body radiotherapy:1||clinical trials:1||lymph node metastasis:1||cancer:1||EQ5D:1||Clinical practice pattern:1||combined modality therapy:1||Nonscattering gel:1||2D and 3D margin:1||tumor response:1||Gel dosimeter:1||Virtual organ delineation (VOD):1||Optimal wavelength:1||Absorbance:1||Glands:1||highdose:1||MVCT:1||Radiotherapy dosage:1||Imageguided radiation therapy:1||onboard imagers:1||pelvic irradiation:1||Heart:1||Tumor molecular subtype:1||residual tumor volume:1||Survival:1||lymph node:1||Breast reconstruction:1||Health care:1||Clinical trials:1||ChildPugh B:1||Hepatic toxicity:1||Esophagitis:1||Metaruleguided mining:1||quality of life:1||Gender:1||Right atrium:1||Elderly:1||Korea:1||prostate cancer:1||radiation treatment planning (RTP) system:1||EORTCQLQBR23:1||Sequence:1||Adenocarcinoma:1||Breast size:1||Doseresponse relationship:1||organ at risk:1||Setup error:1||Automatic registration control:1||Scan image control:1||동시항암화학방사선치료:1||Deep inspiration breath holding:1||NSCLC IIIC:1||response:1||Gallbladder neoplasm:1||Major complication:1||reirradiation:1||Reirradiation:1||Quality:1||Survival rate:1||questionnaire:1||Organ movement:1||Life expectancy:1||Dosimetric index:1||predictive modelling:1||Lymphadenectomy:1||IMRT:1||Adenosquamous carcinoma:1||consistency:1||Pituitary adenoma:1||Rectal cancer:1||prognostic factors:1||예후인자:1||pathologic tumor regression grade:1||radiomics:1||D2 gastrectomy:1||gastric cancer:1||mastectomy:1||Network metaanalysis:1||Radiosurgery:1||New Paradigm for Radiotherapy Payment:1||Efficacy:1||Body mass index:1||Inferior vena cava:1||Scoring system:1||interruption:1||Radiochromic gel:1||Radiological properties:1||Locoregional Control:1||Vaginal Neoplasms:1||Dose volume histogram:1||(DRESS)DP:1||Conebeam computed tomography:1||breast reconstruction:1||Risk factor:1||Electronic portal image:1||Proctitis:1||preoperative chemoradiotherapy:1||코인두암:1||ALBI grade:1||supraclavicular lymph node:1||Neoplasm Metastasis:1||Pattern of care study:1||South Korea:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE